Researchers from Japan find that an engineered version of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, effectively reduces the rate and severity of infection with the Omicron variant under laboratory conditions
Title Image SP:
<plone.namedfile.file.NamedBlobImage object at 0x7fed0eb6ca50 oid 0x4cef87 in <Connection at 7fee02b74dc0>>
Announcement Date
2022-04-27
Research Highlight
Term Index
{'items': [{'key': '7vhh0', 'term': '', 'description': {'blocks': [{'key': '4a24f', 'text': '', 'type': 'unstyled', 'depth': 0, 'inlineStyleRanges': [], 'entityRanges': [], 'data': {}}], 'entityMap': {}}}]}
Departments
['rimd', 'protein', 'accs']
Related Teachers
['Junichi Takagi', 'Toru Okamoto', 'Daron M. Standley']
Teacher Comment
Teacher Image
Teacher Name
Teacher Position
Teacher Division1
Teacher Division2
Teacher URL